Spero Therapeutics
SPRO
SPRO
56 hedge funds and large institutions have $20.8M invested in Spero Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.2% less ownership
Funds ownership: 27.52% → 27.32% (-0.2%)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
86% less call options, than puts
Call options by funds: $26K | Put options by funds: $180K
Holders
56
Holding in Top 10
1
Calls
$26K
Puts
$180K
Top Buyers
| 1 | +$679K | |
| 2 | +$265K | |
| 3 | +$250K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$145K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$145K |
Top Sellers
| 1 | -$1.33M | |
| 2 | -$175K | |
| 3 | -$93.4K | |
| 4 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$62.2K |
| 5 |
AVAI
Atlas Venture Associates IX
Boston,
Massachusetts
|
-$34.3K |